Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update Oct 8, 2018 02:00AM
Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update Oct 8, 2018 02:00AM
Akers Biosciences Announces Q2 and H1 2018 Earnings Aug 14, 2018 04:18PM
Akers Biosciences Announces Q2 and H1 2018 Earnings Aug 14, 2018 04:18PM
Akers Biosciences Announces Lifting of Temporary Suspension of Trading on the London Stock Exchange Jul 26, 2018 07:00AM
View Older Stories

Jul 26, 2018 07:00AM Akers Biosciences Announces Lifting of Temporary Suspension of Trading on the London Stock Exchange
Jul 18, 2018 07:01AM Akers Biosciences Signs a Further Independent Sales Representative Organization for Heparin PF4 Rapid Test Covering Additional 12 States
Jul 18, 2018 07:01AM Akers Biosciences Signs a Further Independent Sales Representative Organization for Heparin PF4 Rapid Test Covering Additional 12 States
Jul 13, 2018 07:12PM Akers Biosciences Announces Q1 2018 Earnings
Jul 13, 2018 07:12PM Akers Biosciences Announces Q1 2018 Earnings
Jul 13, 2018 06:24PM Akers Biosciences Files Restated Previously Issued Financial Statements for 2017
Jul 13, 2018 06:24PM Akers Biosciences Files Restated Previously Issued Financial Statements for 2017
Jul 3, 2018 07:00AM Akers Biosciences Further Extends Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test
Jul 3, 2018 07:00AM Akers Biosciences Further Extends Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test
Jun 29, 2018 07:00AM Akers Biosciences Requests Temporary Suspension of Trading on London Stock Exchange
Jun 29, 2018 07:00AM Akers Biosciences Requests Temporary Suspension of Trading on London Stock Exchange
May 30, 2018 06:09PM Akers Biosciences Granted 180-Day Extension by Nasdaq to Meet Minimum Bid Price Requirement
May 30, 2018 06:09PM Akers Biosciences Granted 180-Day Extension by Nasdaq to Meet Minimum Bid Price Requirement
May 29, 2018 07:08AM Akers Biosciences (AKER) Announces Raymond Akers has Resigned as Director
May 29, 2018 07:01AM Akers Biosciences (AKER) Withdraws FDA 510(k) Submission for PIFA Chlamydia Rapid Assay Pending Further Evaluation
May 29, 2018 07:00AM Akers Biosciences Withdraws FDA 510(k) Submission for PIFA Chlamydia Rapid Assay Pending Further Evaluation
May 29, 2018 07:00AM Akers Biosciences Announces a Change to the Board of Directors
May 29, 2018 07:00AM Akers Biosciences Withdraws FDA 510(k) Submission for PIFA Chlamydia Rapid Assay Pending Further Evaluation
May 29, 2018 07:00AM Akers Biosciences Announces a Change to the Board of Directors
May 25, 2018 04:30PM Akers Biosciences Receives Notice of Delinquent Form 10-Q Filing from Nasdaq
May 25, 2018 04:30PM Akers Biosciences Receives Notice of Delinquent Form 10-Q Filing from Nasdaq
Apr 12, 2018 07:04AM Akers Biosciences (AKER) Announces Expansion of Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test
Apr 12, 2018 07:00AM Akers Biosciences Expands Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test
Apr 12, 2018 07:00AM Akers Biosciences Expands Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test
Apr 3, 2018 07:08AM Akers Biosciences (AKER) Reports FY17 Revenue of $3.93M
Apr 3, 2018 07:03AM Akers Biosciences Reports Earnings for Fiscal Year 2017
Apr 3, 2018 07:03AM Akers Biosciences Reports Earnings for Fiscal Year 2017
Mar 28, 2018 11:20AM Akers Biosciences Announces Rescheduled Conference Call to Discuss Fiscal Year 2017 Earnings
Mar 28, 2018 11:20AM Akers Biosciences Announces Rescheduled Conference Call to Discuss Fiscal Year 2017 Earnings
Mar 26, 2018 07:05AM Akers Biosciences (AKER) Enters US Distribution Agreement with Diagnostica Stago
Mar 26, 2018 07:00AM Akers Biosciences Signs US Distribution Agreement with Diagnostica Stago
Mar 26, 2018 07:00AM Akers Biosciences Signs US Distribution Agreement with Diagnostica Stago
Mar 15, 2018 01:11PM Akers Biosciences Announces Conference Call to Discuss Fiscal Year 2017 Earnings
Mar 15, 2018 01:11PM Akers Biosciences Announces Conference Call to Discuss Fiscal Year 2017 Earnings
Dec 21, 2017 04:58PM Akers Biosciences Announces Closing of $6,900,000 Public Offering
Dec 21, 2017 04:58PM Akers Biosciences Announces Closing of $6,900,000 Public Offering
Dec 19, 2017 05:38AM Akers Biosciences (AKER) Prices 15.5M Share Common Offering at $0.15/Sh
Dec 18, 2017 10:01PM Akers Biosciences Prices $6,000,000 Public Offering
Dec 18, 2017 10:01PM Akers Biosciences Prices $6,000,000 Public Offering
Dec 8, 2017 10:31AM Akers Biosciences Secures Further Intellectual Property Protection for Akers Wellness Line
Dec 8, 2017 10:31AM Akers Biosciences Secures Further Intellectual Property Protection for Akers Wellness Line
Nov 15, 2017 07:00AM Akers Biosciences Announces Q3 2017 Earnings
Nov 14, 2017 07:00AM Akers Biosciences’ UK Distributor Secures New Channel for Rapid Alcohol Breathalyzer
Nov 13, 2017 09:00AM Akers Biosciences Announces Conference Call to Discuss Q3 2017 Earnings
Sep 7, 2017 07:00AM Akers Biosciences Hires Medical Device Specialist to Lead US Sales and Distribution
Aug 15, 2017 07:00AM Akers Biosciences Announces Q2 2017 Earnings
Aug 8, 2017 07:00AM Akers Biosciences Announces Board Changes
Aug 3, 2017 11:39AM Akers Biosciences Announces Second Quarter Trading Update
May 16, 2017 07:00AM Akers Biosciences Announces Q1 2017 Earnings
May 12, 2017 09:36AM Akers Biosciences Announces Conference Call to Discuss Q1 2017 Earnings
View Older Stories